In vivo induction of interleukin-1 during hemodialysis. In vivo induction of interleukin-1 (IL-i) production during hemodialysis was investigated by measuring IL-I activity in monocyte lysates from 59 patients undergoing long-term maintenance hemodialysis with complement activating and non-complement activating devices. In patients dialyzed with new hollow-fiber cuprophane dialyzers, predialytic (TO) monocyteassociated IL-i activity was 12.5 3.0 U/ml (mean SEM), a value that was higher than that found in normal individuals (2.85 0.85 U/mi; P <0.0025) and in non-dialyzed patients with chronic renal failure (0.95 0.85 U/ml, P < 0.0001). Cell-associated IL-i activity was consistently increased after five hours of dialysis with cuprophane membranes (42.4 5.5 U/mI, P < 0.0005). Systemic complement activation was demonstrated by the finding of increased plasma levels of C3adesArg antigen during dialysis. In patients dialyzed with high permeability polyacrylonitrile and polysulfone membranes, no intradialytic change in cellassociated IL-i and no complement activation occurred. However, the mean predialytic values of monocyte-associated IL-I in these patients (that is, 32.9 5.6 U/mI and 38 5.65 U/mI for the polyacrylonitrile and the polysulfone groups, respectively) were higher than the predialytic levels of cell-associated IL-I in the patients from the cuprophane group (P < 0.0025). Monocytes obtained at the beginning and five hours of dialysis from patients dialyzed with polyacryionitrile devices, and monocytes obtained at five hours but not at the beginning of dialysis from patients dialyzed with cuprophane membranes, spontaneously released extracellular IL-I after 24 hours of culture in serum free conditions. Neither polyacrylonitrile nor cuprophane differed in their capacity to stimulate monocytes that had adhered to the membrane, to produce IL-l in serum free cultures. These results indicate that IL-I is transiently generated during hemodialysis with complement activating membranes when C3aiC3adesArg and CsaiC5adesArg, which are known inducers of IL-i production, are generated in plasma. Noncomplement dependent factors, possibly LPS or fragments of LPS that often contaminate bicarbonate dialysates, may be responsible for chronic stimulation of IL-1 production in patients dialyzed with high permeability membranes.
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The present study demonstrates that IL-i is transiently and consistently generated in vivo during hemodialysis with complement-activating cuprophane membranes; we also report that monocytes from patients dialyzed with complement-biocompatible polyacrylonitrile and polysuifone membranes are chronically stimulated to produce IL-1, although in most patients no intradialytic increase in IL-i production is observed.
Methods

Study population
An increasing interest is devoted to the understanding of the deleterious consequences of blood/membrane interactions in extracorporeal devices [1] . Complement activation which occurs during hemodialysis [2] is determined by the type of dialysis membrane [3] [4] [5] , whether it is new or re-used [6] , and by unidentified individual factors [7] . Complement activation consistently occurs in patients dialyzed with new cuprophane hollow-fiber dialyzers, which results in generation in the circu-Received for publication June 20, 1988 and in revised form November 18, 1988 Accepted for publication November 29, 1988 © 1989 by the International Society of Nephrology Fifty-nine long-term chronic hemodialysis patients undergoing five hours of maintenance hemodialysis three times a week in the same outpatient dialysis center were chosen for the study. Informed consent was obtained. Patients included 31 men and 28 women ranging in age from 16 to 72 years (mean age: 37.3). The original nephropathy was chronic glomerulonephritis (31 patients), interstitial nephritis (17 patients), nephroangiosclerosis (2 patients), polycystic kidney disease (2 patients) or undetermined (7 patients). All patients had been on maintenance hemodialysis for more than 12 months and had been dialyzed using the same type of membrane for over two months at the time of the study. Twenty-one patients were undergoing hemodialysis with new cuprophane hollow-fiber dialyzers (Hemofrance, l'Arbresle, France; Gambro, Lund, Sweden; Fresenius, Bad Homburg, FRG); 22 patients were dialyzed with polyacrylonitrile sheet membrane devices (AN69, Hospal, Lyon, France); 16 patients were dialyzed with polysulfone fiber dialyzers (Fresenius F50 and F60). Bicarbonate dialysate (Pharmacie Centrale des Hôpitaux de Paris, Paris, France) was used in all patients. The endotoxin content of the dialysates used at the time of the study has not been determined. However, the same batches of concentrate were used in patients dialyzed with Cuprophane and in patients dialyzed with high permeability membranes. When tested at monthly intervals for one year, the endotoxin content in bicarbonate concentrates ranged from 2.5 to 270.0 EU/mI and that in the treated water ranged from 0-10 EU/mi, as assessed using a commercial colorimetric Limuius Amebocyte Lysate assay (Wittaber, Walkersville, Massachusetts, USA).
Control subjects were 14 healthy members of the medical staff (age 20 to 50) and 10 non-hemodialyzed patients with chronic renal failure (age 39 to 75; serum creatinine 440 to 1200 jmol/liter) including six patients with chronic glomerulonephritis, three patients with nephroangiosclerosis and one patient with interstitial nephritis.
Preparation of peripheral blood monocytes and IL-I assays
Heparinized blood was obtained predialysis from the patients' arteriovenous fistula and subsequent samples were obtained from the efferent line of the dialyzer during the dialysis session. Peripheral blood mononuclear cells were separated from whole blood by centrifugation on MSL (Eurobio, Paris, France). Monocytes were identified by staining with nonspecific esterase (NSE) using alphanaphtyl acetate as substrate [19] . Mononuclear cells were enriched in monocytes by allowing the cells to adhere to 24-well plastic cultured dishes (Nunc, Röskilde, Denmark) in the absence of serum for 45 minutes. Five hundred microliters of RPM! 1640 (MA Bioproduct) containing 5 x iO NSE-positive cells were plated in each well.
After two vigorous washes with RPM! 1640 containing 100 IU/ ml penicillin and 100 g/ml streptomycin, mononuclear adherent cells were lyzed by three freeze-thaw cycles at -80°C in 0.5 ml RPM! containing antibiotics to extract cell-associated (monocyte-associated) IL-i, as described [20] [21] [22] . Under these conditions, the adherent cells contained more than 85% monocytes, as assessed by morphological analysis by phase contrast microscopy, staining with NSE and indirect immunofluorescence using anti-lymphocyte antibodies OKT1 1 (Ortho Diagnostics, Raritan, New Jersey, USA) and IOBI (Immunotech, Marseille, France). After centrifugation of the monocyte lysates at 2000 x g for 10 minutes at 4°C, IL-I activity was measured in the supernatants by means of a conventional ConA comitogenic assay using C3H/HeJ thymocytes [15] . The freeze-thawing procedure yielded reproducible results since the SD of the mean cell-associated IL-i activity measured in eight lysates of normal LPS-stimulated monocytes (10 tg of Neisseria meningitidis
[Nm] LPS/5 x 1O5 cells) did not exceed 10% (795 U/mI 61). Units of IL-i activity/mi of culture supernatant were calculated as follows:
where cpm of test sample is the mean of (3H)-thymidine incorporated in triplicate cultures of thymocytes performed in the presence of supernatants from monocyte cultures. Background cpm is (3H)-thymidine incorporated in thymocytes cultured in RPM! alone.
Each assay of IL-i activity included cultures performed in the presence of a constant source of monocyte-associated IL-I obtained by stimulation of monocytes of one individual with 10 p.g/5 X i05 cells of Nm LPS as the internal standard. The internal standard contained 1000 U/mi of thymocyte-stimulating activity and 2.2 ng/ml of IL-i beta antigen as determined using a commercial radioimmunoassay.
In additional experiments, monocytes from five patients dialyzed with cuprophane membranes and five patients dialyzed with a polyacrylonitrile membrane were cultured in the absence of serum (5 x i05 NSE cells in 0.5 ml RPM! containing antibiotics/well) for 24 hours at 37°C in the presence of 5% CO2.
After centrifugation, IL-i activity released in the supernatants was assayed on inurine thymocytes. RPM! contained no detectable LPS as assessed using the Limulus assay.
Complement assays For measurement of plasma concentrations of C3adesArg
antigen, blood was obtained at times 0, 15 minutes and 5 hours of dialysis in tubes containing ethylenediamine tetraacetate (EDTA, 5 mii final). Samples were immediately centrifuged at 4°C and the plasma was stored at -80°C until processing. C3adesArg antigen levels were determined using the radioimmunoassay developed by Upjohn (Upjohn Co, Kalamazoo, Michigan, USA) [231.
Statistics
All grouped data are reported as means SEM. Statistical analysis was performed with Student's 1-test. Materials LPS from Neisseria meningitidis was from Dr. D. Schultz, Institut Mérieux, Lyon, France. Rabbit anti-human IL-i antiserum was obtained from Genzyme (Genzyme Corp., Boston, Massachusetts, USA). The radioimmunoassay for IL-I beta was from Cistron Biotechnology, Pine Brook, New Jersey, USA. For in vitro experiments investigating the ability of dialysis membranes to trigger monocyte production of IL-i, small sterile dishes of Cuprophane and polyacrylonitrile (from C. Pusineri, Hospal, Lyon, France) were used. The diameter of the disc was that of a culture well of 24-well plastic cultures dishes.
Results
Monocyte-associated IL-i activity was measured at the beginning and after five hours of hemodialysis in patients undergoing hemodialysis with first use cuprophane, polyacrylonitrile and polysuifone membranes. At the beginning of the session (TO), the mean monocyte-associated IL-i activity in 21 patients undergoing dialysis with cuprophane membranes was 12.5 3.0 U/mI, a number which was higher than that measured in 14 healthy individuals (2.85 0.85 U/mI; P < 0,0025) and in 10 non-dialyzed patients with chronic renal failure (0.95 0.85; P < 0.0001). After five hours of hemodialysis, monocyte-associate IL-i activity increased in 16 of2l patients to reach a mean background cpm value of 42. 4 5.53 U/mi (P < 0.0005, Fig. 1 ). The mean monocyte count in these patients decreased by 21.3 4% (mean SEM) at the end of dialysis as compared with predialysis counts. In 22 patients undergoing hemodialysis with poiyacrylonitrile membranes, a high value of monocyte-associated IL-I activity of 32.9 5.6 U/mI was found at TO. The latter value was significantly different from that observed at TO in the group of patients dialyzed with cuprophane dialyzers (P < 0.0025) and from that measured in healthy individuals (P < 0.0005) and in non-dialyzed patients with chronic renal failure (P < 0.0005). After five hours of dialysis (T5h) with polyacrylonitrile membranes, monocyte-associated IL-I activity increased in 5 of 22 patients, whereas it decreased or remained at predialysis levels in the majority of the patients. Mean monocyte-associated IL-l activity at T5h was 59.2 7.0 U/mi, which represented an increase over predialysis values (P < 0.01). In 16 patients dialyzed with polysulfone fibers, the mean value of monocyte-associated IL-i activity was 38 5.65 U/mI at TO, which was significantly higher than in the cuprophane group at TO (P < 0.0025). It was 36.5 6.7 U/mI after T5h of hemodialysis, a value that was not different from that measured at TO in this group of patients.
Monocyte-associated IL-i activity that was detected in cell lysates using the thymocyte proliferation assay was inhibited in a dose-dependent manner by polyclonal anti-IL-i antibodies when used at a 1/50 to a 1/500 dilution. The ratio between IL-i activity and concentrations of IL-i beta antigen in cell lysates from patients' monocytes was similar to that between IL-I activity and IL-l beta antigen in cell lysates from normal monocytes stimulated with LPS. To examine whether low predialytic levels of cell-associated IL-1 in patients dialyzed with cupropharie membranes were due to the presence of (a) circulating IL-I inhibitor(s) that would not be dialyzed with low molecular weight cut-off membranes, various amounts of lyzates from monocytes obtained at TO from three patients in the cuprophane group were mixed with dilutions of lyzates from normal LPS-stimulated monocytes that yielded half maximal values for IL-I activity in the thymocyte proliferation assay. No inhibition of IL-i activity was observed.
The kinetics of increase in monocyte-associated IL-i activity in patients dialyzed with cuprophane dialyzers were studied in five individuals. Two patients demonstrated increased values of cell-associated IL-i as soon as two hours after the beginning of dialysis. In four of five patients, monocyte-associated IL-i increased by at least twofold at the end of dialysis (Fig. 2 ). As shown in Table 1 , the relative intradialytic increase in monocyte-associated IL-I was similar when tested during repeated dialysis sessions in a given patient.
Measurements of the plasma concentration of C3adesArg antigen could be obtained in 13 of the patients undergoing hemodialysis with cuprophane membranes and 10 of the patients dialyzed with polyacrylonitrile membranes. In patients from the cuprophane group, C3adesArg levels increased from a mean predialysis value of 170 S ng/ml to 1154 76 ng/ml in the efferent sample at 15 minutes after dialysis (T15 mm; that is, a 6.8-fold increase). C3adesArg levels decreased to 453 45 ng/ ml at the end of dialysis. In five patients in this group in whom monocyte-associated IL-I was below 10 U/mI at TO, the relative intradialytic increase in cell-associated IL-i was correlated with the relative increase in C3adesArg levels between TO and T15 mm (r = 0.75). In patients dialyzed with polyacryionitrile dialyzers, C3adesArg levels were 206 20 ng/ml at TO, 336 7.3 ng/ml at Tl5 mm (a 1.6-fold increase) and 258 26 nglml at T5h. In order to assess whether increased values of monocyteassociated IL-I activity that were observed in hemodialyzed patients may reflect IL-I activity that could be further released in plasma in vivo, monocytes were isolated from blood samples obtained at TO and T5h of hemodialysis, and cultured for 24 hours in the absence of serum. Spontaneous release of IL-i activity in the culture supernatant was then assessed. Little or no IL-i activity (mean = 0.12 0.11 U/mI) was released by cultured monocytes that had been obtained at TO from five patients dialyzed with cuprophane membranes who were tested. A mean of 9.9 2.51 U/mI of IL-i activity was released by cultured monocytes that had been obtained from these patients after five hours of hemodialysis (Table 2 ). In contrast, high amounts (mean = 25.3 11.61 U/mi) of spontaneously released IL-l were found in supernatants of cultured monocytes that had been obtained at TO from five patients dialyzed with polyacrylonitrile devices. Spontaneously released IL-1 increased only twofold after five hours of hemodialysis in these patients (mean = 22.1 U/ml). Monocytes from 14 normal donors cultured for 24 hours under the same conditions in the presence of 1 g/ml of Nm LPS, released a mean IL-i activity of 155 U/ ml (30 to 330 U/mI).
To investigate whether the dialysis membranes may directly trigger synthesis of IL-I in monocytes, monocytes (5 x l0/ well) from four normal individuals were allowed to adhere for 45 minutes to plastic culture dishes or to wells that had been pre-coated with cuprophane or polyacrylonitrile, and further cultured for five hours in serum-free conditions. The number of NSE trypsin-detachable cells that had adhered to the surfaces were 6.09 x lO, 5.10 x iO and 5.64 X iO cells/well for control plastic culture dishes, cuprophane and polyacrylonitrile, respectively. The 45-minute adherence period was insufficient to trigger IL-i synthesis by cells in contact with any of the surfaces, as assessed by measuring cell-associated IL-1 activity (Fig. 3) . During the five-hour culture period, a time-dependent stimulation of IL-i synthesis was observed on monocytes cultured on plastic dishes in the absence of serum. No difference in the amount of cell-associated IL-i activity that was produced was found between cells cultured on plastic and cells cultured either on cuprophane or on polyacrylonitrile. No significant adsorption capacity for IL-I of cuprophane and polyacrylonitrile membranes was found in control experiments in which a source of cell-associated IL-i was incubated in wells that had been precoated with the membranes for five hours at 22°C.
Discussion
Interleukin-i (IL-i) is a critical mediator of the inflammatory reaction that induces a wide range of biological effects at the site of inflammation and in distant organ targets [13, 18] . LPS [14, 181 and the complement-derived fragments C3adesArg and C5adesArg [16, 171 induce production of IL-l and IL-l release from human monocytes. IL-i is not preformed in unstimulated cells [21, 241. After stimulation with LPS, cytoplasmic pro IL-1 mRNA can be detected within two hours in vitro [25] . Intracellular protein and IL-i activity parallel the IL-l message level [25] . Cell-associated IL-i activity preceeds by at least four hours the release of IL-I in culture supernatants [26, 271 . Some of the adverse effects that may follow exposure of whole blood to dialysis membranes, including fever, hypotension [i2] and, possibly, the late occurrence of amyloidosis have been suggested to be mediated by IL-l. The present study provides direct evidence for enhanced production of IL-i in hemodialyzed patients.
We investigated monocyte-associated IL-l activity rather than circulating IL-i for the following reasons: 1) the presence in human plasma of IL-i inhibitors [28] and of factors that may interfere with the thymocyte proliferative assay for IL-i activity (29) ; the unlikelihood of generation of detectable amounts of released IL-l in plasma during the five hours of hemodialysis. Thus, IL-l activity is found in cell lysates after five hours of At the beginning of dialysis (TO), low levels of monocyteassociated IL-I activity were found in all patients undergoing maintenance hemodialysis with new hollow-fiber cuprophane dialyzers. The mean value of cell-associated IL-i in these patients was higher than that which was measured in monocytes from 14 normal individuals and from 10 non-dialyzed patients with chronic renal failure. High amounts of monocyte-associated IL-1, equivalent to 20% of the amount that is found in normal monocytes cultured for five hours in the presence of 1 p.g/ml Nm LPS, were found at TO in patients dialyzed with polyacrylonitrile and with polysulfone devices. Monocytes at TO of polyacrylonitrile dialysis were not maximally stimulated since the cells could further be triggered in vitro if cultured in the presence of exogenous LPS (data not shown). Taken together, these observations suggest that, three days after a dialysis session, monocytes from patients dialyzed with high permeability membranes were stimulated in vivo to produce IL-i. Furthermore, no IL-i was found to be released from monocytes obtained at TO from five patients dialyzed with cuprophane membranes and cultured for 24 hours in the absence of serum and exogenous stimulus, whereas monocytes obtained at TO from five patients in the polyacrylonitrile group released significant amounts of IL-i under similar culture conditions. In both groups of patients, plasma concentrations of C3adesArg antigen at TO were within the limit of normals. The nature of the complement-independent IL-i inducer that stimulates monocytes in vivo in patients undergoing hemodialysis with high permeability non-complement activating membranes is unknown at the present time. One possible explanation would be the passage of rough LPS and/or fragments of LPS with molecular weights between 2800 and 4800 daltons [30] through polyacrylonitrile and polysulfone membranes. Preliminary results from recently performed experiments indicate that radiolabeled Nm LPS may cross polyacrylonitrile membranes in vitro [31] . Cultured monocytes that have been in contact with LPS for five hours continue to produce cell-associated IL-i 72 hours after removal of the stimulus (unpublished observations). Intravenously injected LPS may persist for several days in the circulation in experimental animals [32] . Low amounts of cell-associated IL-i found at TO in the cuprophane group could represent residual IL-I from the previous dialysis session or IL-i induced by other factors than intact LPS, of which no passage has been observed through cuprophane membranes [33] [34] [35] . Neither polyacrylonitrile nor cuprophane were found to differ in their capacity to directly stimulate monocytes that had adhered to these membranes to produce IL-i serum free cultures in vitro.
In patients undergoing hemodialysis with new cuprophane hollow-fiber dialyzers, monocyte-associated IL-i was significantly increased at the end of dialysis as compared with values obtained at TO. Similar results were obtained in five patients dialyzed with cuprophane flat sheet devices (data not shown). The half life of monocytes exceeds 24 hours [36] , suggesting that monocytes which were found to produce IL-l at the end of dialysis were representative of the monocyte population circulating at the beginning of the session. Significant amounts of IL-i were spontaneously released in supernatants of serum-free 24 hour cultures of monocytes obtained from cuprophane patients at the end of the dialysis session, although the cells could further be stimulated by addition of LPS to the cultures (data not shown). The amount of IL-i that was spontaneously released by monocytes under these conditions represented approximately 10 to 20% of that which would be released by monocytes from normal individuals in the presence of 1 gIml Nm LPS in serum free conditions. Release of IL-i by unstimulated cultured monocytes from the patients may be an indirect indication that IL-i may be released in vivo in the hours following the end of the dialysis procedure, the time at which fever occurs in hemodialyzed patients. Complement activation may be directly involved in triggering the intradialytic increase of IL-i production that was observed with cuprophane membranes. C3a was generated during dialysis in all patients from the cuprophane group. A correlation was found between intradialytic increases in IL-l production and C3adesArg levels in patients in whom amounts of cell-associated IL-i were low at TO. The latter correlation was not found if all patients from the cuprophane group were considered, which may be due to the differences that exist between individuals in their ability to produce IL-i upon stimulation with anaphylatoxins [16, 17] . Multiple factors may determine the actual extent of complement-dependent IL-1 production during cuprophane hemodialysis, including: the amount of C3alC3adesArg produced, which depends on individual responses to cellulose [7, 371; the relative efficiency of C5a versus C3a production during complement activation [38] ; the individual monocytic response to C3a1 C3adesArg [17] and C3a/C3adesArg [161; and the putative presence of IL-i inhibitors of monocytic origin [29] released in response to activated complement. In contrast, no intradialytic increase in IL-l production was found in most patients undergoing dialysis with polyacrylonitrile and with polysulfone membranes in whom no complement activation occurred during dialysis. C3a'C3adesArg induces IL-l production from monocytes in vitro at concentrations equivalent to those found in the plasma of patients dialyzed with cuprophane membranes [171. In addition, elevated levels of C3a may be an indirect indication of in vivo generation of C5a, which also triggers monocytes to produce IL-i [16, 17] . Thus, transient activation of complement in the cuprophane group may provide a mechanism for initiating the transient stimulation of IL-l production in the patients.
The demonstration of increased IL-i production is another example of the adverse effects that may occur during hemodialysis 139]. Transient IL-l production occurs in patients dialyzed with complement activating membranes. In patients dialyzed with high-permeability polyacrylonitrile and polysulfone devices, biocompatibility of the membrane for the complement system appears to be counter-balanced, at least in some patients, by chronic stimulation of IL-I production. The long-term effects of intermittent and chronic stimulation of IL-i production in hemodialyzed patients remain to be established.
